When is the best time of day for cancer treatment?
Researchers from Charité are developing new methods to use the internal clock inside tumor cells to optimize cancer therapies
4 Min
More 
A new culprit in Huntington’s disease
Researchers in Berlin and Düsseldorf have implicated a new gene in the progression of Huntington’s disease in a brain organoid model. The gene may contribute to brain abnormalities much earlier than previously thought. The study was published in…
4 Min
More Reinforcement for the knee: 3D bioprinting with the body's own cartilage cells
Sporting activities promote our health but can lead to injuries of the musculoskeletal system if not performed correctly. This often affects the cartilage in the joints. Untreated cartilage defects can lead to osteoarthritis at older age, for which…
3 Min
More Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden
In the presence of the Saxon State Ministers Martin Dulig and Thomas Schmidt as well as the Mayor of Dresden Dirk Hilbert, the medical technology company Eckert & Ziegler today inaugurated its new 1,700 square meter facilities in Dresden with around…
2 Min
More Caresyntax Raises $180 Million Funding to Accelerate Growth and Adoption of Precision Surgery
Caresyntax, a vendor-neutral precision surgery platform, is pleased to announce raising a total commitment of $180 million through a series C extension and growth debt expansion round.
7 Min
More Surprising mechanism of lupus kidney damage identified
A team led by Charité – Universitätsmedizin Berlin, German Rheumatology Research Center (DRFZ) and Max Delbrück Center have defined key cells behind severe kidney damage in lupus. The research, published in Nature,* could inform future antibody…
4 Min
More Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
Eckert & Ziegler and Telix Pharmaceuticals Limited (Telix) today announced the signing of a significant multi-year agreement under which Eckert & Ziegler will serve as the European contract manufacturing organization (CMO) for Telix's ProstACT GLOBAL…
2 Min
More New Molecular Insights into Bariatric Surgery's Impact on Obesity and Type 2 Diabetes
Researchers from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) and the German Center for Diabetes Research (DZD) have gained insights shedding light on the molecular adaptations occurring in skeletal muscle following bariatric…
3 Min
More Successful Fasting Requires Spermidine
The protective effects of fasting depend on an increase in the concentration of spermidine, according to an international study involving a team led by Professor Stephan Sigrist from Freie Universität Berlin.
3 Min
More SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers
- SphingoTec GmbH has successfully secured funding to drive its global expansion, including the US market, through strategic collaborations.
- The investment round is led by Think.Health Ventures, with support from existing investors. Think.Health…
2 Min
More Show more items
